Whistleblower

Company news: FDA's "Stasi" scheme; Thermo Fisher Scientific and One Lambda; Forest Labs

Sen. Chuck Grassley unloaded on the FDA as a scandal over agency monitoring of dissident employee emails continued to unfold.

DOJ hit pharmas for $2.2 billion in 2011 False Claims Act cases

DOJ hit pharmas for $2.2 billion in 2011 False Claims Act cases

By

Pharmas shelled out $2.2 billion in False Claims Act fines and settlements with the Justice Department this year as the feds' healthcare fraud haul hit an all-time high.

Pain drug monitoring firm enticed docs to use test, qui-tam suit charges

By

A national lab promised doctors they could enrich themselves by as much as $2 million a year through a scheme that involved billing payers multiple times for the same urinary drug test, a whistleblower suit alleges.

Sales reps at J&J unit to get 'ride-alongs' as part of CIA

By

As part of an $81 million off-label settlement with the Department of Justice (DOJ), Ortho-McNeil Janssen Pharmaceuticals Inc. (OMJPI) sales reps will be buddied up with internal compliance monitors tasked with observing and reporting the rep's behavior out in the field.

AstraZeneca settles Seroquel off-label suit for $520m, CIA

AstraZeneca settles Seroquel off-label suit for $520m, CIA

By

AstraZeneca agreed to pay $520 million and enter a five-year Corporate Integrity Agreement to settle a federal case against the company for off-label marketing of Seroquel, the Departments of Justice and Health and Human Services' Healthcare Enforcement Action Team announced.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters